- Effect of Pravastatin on Serum Lipids of Patient with Primary Hyperlipidemia
-
Yoo WS, Koh WS, Cho BY, Choi SK
- KMID: 2229394
- Korean Circ J.
- 1990 Mar;20(1):128-134.
- doi: 10.4070/kcj.1990.20.1.128
A new hypolipidemic drug, pravastatin, hydroxymethylglutaryl coenzyme A reductase inhibitor was administered to 33 patients with primary hyperlipidemia, 10mg daily for 8 weeks and sequential changes of lipid profile were... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Pravastatin in Patients with Hypercholesterolemia
-
Kim JS, Han KH, Park SW, Bang JK, Hong SK, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW
- KMID: 2093361
- Korean Circ J.
- 1992 Feb;22(1):113-120.
- doi: 10.4070/kcj.1992.22.1.113
BACKGROUND: This study was designed to evaluate the clinical efficacy of pravastatin, HMG-CoA reductase inhibitor, in patients with hypercholesterolemia. Methods and RESULTS: Pravastatin 5 mg was administered twice daily for 12... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term hypolipidemic effect and safety of pravastatin compared with cessation of therapy in patients with hyperlipidemia
-
Kim SH, Kim YS, Kang HS, Cho JW, Kim KS, Kim MS, Song JS, Bae JH
- KMID: 2229204
- Korean Circ J.
- 1993 Feb;23(1):142-148.
- doi: 10.4070/kcj.1993.23.1.142
BACKGROUND: Hyperlipidemia is the one of the major risk factors causing the atherosclerosis of coronary arteries. Treatment of hyperlipidemia with drugs has been confirmed the effcts of therapy showing a... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-Term Hypolipidemic Effects of Pravastatin in Patients with Hyperlipidemia
-
Bae JH, Kang HS, Kim KS, Kim MS, Song JS
- KMID: 2093364
- Korean Circ J.
- 1992 Feb;22(1):140-145.
- doi: 10.4070/kcj.1992.22.1.140
BACKGROUND: Hyperlipidemia is the one of the major risk factors causing the atherosclerosis of coronary arteries. Treatment of hyperlipidemia with drugs has been confirmed the effects of therapy showing a... -
- CITED
-
- Close
- SHARE
-
- Close
- Pravastatin-induced Stevens-Johnson syndrome
-
Yu JE, Choi YH, Jeong J, Cho KM, Koh YI
- KMID: 2218634
- Allergy Asthma Respir Dis.
- 2015 Nov;3(6):446-448.
- doi: 10.4168/aard.2015.3.6.446
Stevens-Johnson syndrome (SJS) manifests with severe cutaneous reactions, most commonly triggered by medications, which are characterized by fever and mucocutaneous lesions leading to necrosis and sloughing of the epidermis. To... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of short-term pravastatin therapy in patients with hyperlipidemia
-
Park JW, Ryu KH, Lim CY, Koh YB, Lee Y
- KMID: 2229203
- Korean Circ J.
- 1993 Feb;23(1):136-141.
- doi: 10.4070/kcj.1993.23.1.136
BACKGROUND: Pravastatin, HMG-CoA reductase inhibitor, has been known to be the most effective drug in patients with hypercholesterolemia. We studied the effectiveness and side effects of this drug. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Pravastatin on Insulin Resistance in Hyperglycemic Patients
-
Jeong YJ, Kim JM, Jang SJ, Bang JH, Jung YG, Kim ST, Kang SH, Choi JI, Kim SS, Kang MY
- KMID: 2374769
- J Korean Diabetes.
- 2017 Mar;18(1):53-61.
- doi: 10.4093/jkd.2017.18.1.53
BACKGROUND: The effect of pravastatin on insulin resistance (IR) is controversial and poorly studied in prediabetes. METHODS: This study was performed in hyperglycemic patients at Saint Carollo Hospital from January 1,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Pravastatin Monotherapy in Patients with Hypercholesterolemia
-
Kim JJ, Song JK, Park SW, Park SK, Park SJ, Lee SJ
- KMID: 2093363
- Korean Circ J.
- 1992 Feb;22(1):130-139.
- doi: 10.4070/kcj.1992.22.1.130
BACKGROUND: The HMG-CoA reductase inhibitor is the most powerful cholesterol lowering drug and lovastatin, simvastatin and pravastatin are used clinically. We studied the efficacy and side effects of pravastatin monotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Pravastatin Monotherapy in Patients with Hypercholesterolemia
-
Kim HS, Lim SW, Yoon YS, Chung NS, Shim WH, Cho SY, Kim SS
- KMID: 2029377
- Korean Circ J.
- 1993 Aug;23(4):614-620.
- doi: 10.4070/kcj.1993.23.4.614
BACKGROUND: HMG-CoA reductase is known as a rate limiting enzyme in the synthesis of cholesterol. We studied the clinical efficacy and the side effects of pravastatin, a HMG-CoA reductase inhibitor,... -
- CITED
-
- Close
- SHARE
-
- Close
- Appropriate candidates for statin use in heart failure
-
Seo HS
- KMID: 2070129
- Korean J Intern Med.
- 2014 Nov;29(6):730-734.
- doi: 10.3904/kjim.2014.29.6.730
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Pravastatin(Mevalotin(R)) in Patients with Hypercholesterolemia
-
Shin YK, Shin YW, Lee DI, Shin JA, Moon CH, Chun KJ
- KMID: 2229185
- Korean Circ J.
- 1992 Apr;22(2):314-321.
- doi: 10.4070/kcj.1992.22.2.314
An open clinical trial was performed to test the efficacy and side effects of Pravastatin(Mevlotin(R)), HMG-CoA reductase inhibitor, administering 5mg twice daily for 12weeks in 30 patients of hypercholesterolemia in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Pravastatin(Mevalotin(R)) on Hyperlipidemia
-
Suh SK, Rhee KJ
- KMID: 2229358
- Korean Circ J.
- 1990 Dec;20(4):784-792.
- doi: 10.4070/kcj.1990.20.4.784
Effects of Pravastatin(Mevalotin(R)), a new HMG-CoA reductase inhibitor on the blood lipids were studied for the period of 3 months in 40 subjects with hypercholesterolemia more than 250mg/dl. Age of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model
-
Liang L, Hur J, Kang JY, Rhee CK, Kim YK, Lee SY
- KMID: 2426406
- Korean J Intern Med.
- 2018 Nov;33(6):1210-1223.
- doi: 10.3904/kjim.2017.207
BACKGROUND/AIMS: The co-occurrence of obesity aggravates asthma symptoms. Diet-induced obesity increases helper T cell (TH) 17 cell differentiation in adipose tissue and the spleen. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pravastatin... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Trial of Pravastatin in Korean Patients with Hypercholesterolemia
-
Park JH, Ahn YG, Jeong MH, Cho JG, Park JC, Choi KC, Kang JC
- KMID: 2229184
- Korean Circ J.
- 1992 Apr;22(2):307-313.
- doi: 10.4070/kcj.1992.22.2.307
Hypercholesterolemia is one of the major risk factors for atherosclerosis. Reduction of serum total and low density lipoprotein cholesterol(LDL-C) and the increase of high density lipoprotein cholesterol(HDL-C) are known to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study
-
Lee HY, Cho HJ, Kim HY, Jeon HK, Shin JH, Kang SM, Baek SH
- KMID: 2070133
- Korean J Intern Med.
- 2014 Nov;29(6):754-763.
- doi: 10.3904/kjim.2014.29.6.754
BACKGROUND/AIMS: This study was designed to evaluate the dose-effect relationship of statins in patients with ischemic congestive heart failure (CHF), since the role of statins in CHF remains unclear. METHODS: The... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of HMG-CoA Reductase Inhibitors on Bone Mass in Postmenopausal Women
-
Lee SY, Kim YJ
- KMID: 2294818
- J Korean Acad Fam Med.
- 2003 May;24(5):451-455.
BACKGROUNG: It is controversial whether the use of HMG CoA reductase inhibitors (statins) is associated with an increased bone mineral density (BMD) in humans. The purpose of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
-
Kong SH, Koo BK, Moon MK
- KMID: 2368526
- Diabetes Metab J.
- 2017 Feb;41(1):23-30.
- doi: 10.4093/dmj.2017.41.1.23
BACKGROUND: There has been evidences of ethnic differences in the low density lipoprotein cholesterol (LDL-C) lowering effect of statin. We aimed to evaluate the efficacy of moderate-intensity statins in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Statin Treatment on Strut Coverage after Drug-Eluting Stent Implantation
-
Suh Y, Kim BK, Shin DH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK
- KMID: 2352788
- Yonsei Med J.
- 2015 Jan;56(1):45-52.
- doi: 10.3349/ymj.2015.56.1.45
PURPOSE: To evaluate the effect of statin treatment on strut coverage after drug-eluting stent (DES) implantation. MATERIALS AND METHODS: In this study, 60 patients were randomly assigned to undergo sirolimus-eluting stent... -
- CITED
-
- Close
- SHARE
-
- Close
- HMG CoA Reductase Inhibitors Inhibit HCV RNA Replication of HCV Genotype 1b but Not 2a
-
Chang KS, Jo HJ
- KMID: 2168627
- J Bacteriol Virol.
- 2011 Jun;41(2):99-108.
- doi: 10.4167/jbv.2011.41.2.99
Replication of hepatitis C virus (HCV) is regulated by statin, one of 3-hydroxy-3-methylglutaryl CoA reducatase (HMG CoA reductase) inhibitors that block mevalonate pathway and cholesterol biosyntheis, which has been used... -
- CITED
-
- Close
- SHARE
-
- Close
- Cholesterol Lowering Effects of Low-dose Statins in Korean Patients
-
Kwon JE, Kim Y, Hyun S, Won H, Shin SY, Lee KJ, Kim SW, Kim TH, Kim CJ
- KMID: 2198357
- J Lipid Atheroscler.
- 2014 Jun;3(1):21-28.
- doi: 10.12997/jla.2014.3.1.21
OBJECTIVE: The aim of this study is to compare cholesterol lowering effects of low dose 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in Korean patients. METHODS: A total of 909 consecutive patients... -
- CITED
-
- Close
- SHARE
-
- Close
